The development, optimization, and validation of a new high-performance liquid chromatography ultraviolet (HPLC-UV) method is presented for determining 2-(3-chlorophenyloamino)-5-(2,4-dihydroxy-phenyl)-1,3,4-thiadiazole (ClABT) in biological samples of rat plasma and brain tissue. ClABT was extracted directly from a plasma supernatant fraction following protein precipitation with acetonitrile and high speed centrifugation. Reverse phase HPLC separation was performed using an ODS-2 Hypersil column with the mobile phase consisting of 0.05 M triethylammonium phosphate buffer solution in acetonitrile and methanol (120:280:600, v/v/v), at room temperature, 1.2 mL min−1 flow rate, and UV-diode-array detection (DAD), at 335 nm. A linear response was obtained between 12.5 and 2000 ng mL−1 at analytically acceptable levels of precision (intra/inter-day) and accuracy. Mean recoveries ranged from 92.7% to 107.9%. It was concluded that the method was specific and precise and thus suitable for quantitative analysis in clinical pharmacokinetic studies of ClABT.
[1]. N. Siddiqui P. Ahujaa W. Ahsana S.N. Pandeyab M. Shamsher 2009 J. Chem. Pharm. Res. 1 19.
[2]. F. Vergne P. Bernardelli E. Lorthiois N. Pham E. Proust Ch. Oliveira A. Mafroud F. Roye R. Wrigglesworth J.K. Schellhaas M.R. Barvian F. Moreau M. Idrissi A. Tertre B. Bertin M. Coupe P. Berna P. Soulard 2004 Bioorg. Med. Chem. Lett. 14 4607.
[3]. K.Y. Jung S.K. Kim Z.G. Gao A.S. Gross N. Melman K.A. Jacobson Y. Ch. Kim 2004 Bioorg. Med. Chem. 12 613.
[4]. P. Bhattacharya J. Leonard K. Roy 2005 Bioorg. Med. Chem. 13 1159.
[5]. J. Matysiak A. Niewiadomy 2006 Synth. Commun. Chem. 36 1621.
[6]. W. Rzeski J. Matysiak M. Kandefer-Szerszeń 2007 Bioorg. Med. Chem. 15 3201.
[7]. M. Juszczak J. Matysiak W. Brzana A. Niewiadomy W. Rzeski 2008 Arzneim. Forsch. Drug Res. 58 353.
[8]. M.S. Chernov'yants I.V. Burykin N.V. Aleshina 2011 J. Anal. Chem. 66 280.
[9]. J.A. Stewart C.C. Ackerly R.A. Newman I.H. Krakoff 1986 Cancer Chemother. Pharmacol. 16 287.
[10]. E. Tomori E. Tormasi M. Varga J. Borlak 1998 J. Chromatogr. B Biomed. Sci. Appl. 705 105.
[11]. J.F. Borzelleca J.L. Egle Jr. G.R. Hennigar H.H. Klein E.J. Kuchar R.W. Lane P.S. Larson 1980 Toxicol. Appl. Pharmacol. 56 164.
[12]. H. Wong J. Lee J.B. Camden S.D. Weitman 2001 J. Chromatogr. B. 765 55.
[13]. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (2001).
[14]. Y. Jiang Y. Zhang Z.R. Zhang 2003 J. Chromatogr. B. 791 285.
[15]. J.I.D. Wibawa D. Fowkes P.N. Shaw D.A. Barrett 2002 J. Chromatogr. B. 774 141.
[16]. C.L. Cheng C.H. Chou O.Y. Hu 2002 J. Chromatogr. B. 769 297.
[17]. M. Zaffaroni C. Mucignat T. Pecere G. Zagotto R. Frapolli M. D'Incalai M. Zucchetti 2003 J. Chromatogr. B. 796 113.
[18]. F. Wu Z. Zhang H. Ding 2006 J. Chromatogr. Sci. 44 12.
[19]. H. Wong L. Jia J.B. Camden S.D. Weitman 2001 J. Chromatogr. B. 765 55.
[20]. B. Narola A.S. Singh P.R. Santhakumar T.G. Chandrashekhar 2010 Anal. Chem. Insights. 5 37.